Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis

Hemodialysis International

Volumn 8, Issue 3, 2004, Pages 207-213

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGING; ANEMIA; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALNUTRITION; MEAN ARTERIAL PRESSURE; MORTALITY; PREDICTION; PROGNOSIS; PULSE PRESSURE; PULSE WAVE; REVIEW; RISK ASSESSMENT; STROKE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; VEIN COMPLIANCE;

EID: 22644445665     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2004.01097.x     Document Type: Review

References (37)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115(4):291-297.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289(19):2560-2572.
3. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999; 33(3):507-517.
4. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levery A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. [published erratum appears in Kidney Int. 1998; 54(4): 1417]. Kidney Int. 1998; 54(2):561-569.
5. Rahman M, Griffin V, Kumar A, Manzoor F, Wright JT Jr, Smith MC. A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 2002; 39(6):1226-1230.
6. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial. 2002; 15(5):299-304.
7. Mansoor GA, White WB. Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. Am J Kidney Dis. 1997; 30(5):591-605.
8. Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001; 60(5):1982-1989.
9. Santos SF, Mendes RB, Santos CA, Dorigo D, Peixoto AJ. Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol. 2003; 23(2):96-105.
10. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000; 36(5):983-990.
11. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000; 57(6):2485-2491.
12. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA. 2004; 291(4):451-459.
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996; 49(5):1379-1385.
14. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y, Nakamura S, Baba S, Matsuoka H, Omae T. Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis. 1995; 25(3):405-412.
15. Kimura G, Tomita J, Nakamura S, Uzu T, Inenaga T. Interaction between hypertension and other cardiovascular risk factors in survival of hemodialyzed patients. Am J Hypertens. 1996; 9(10 Pt 1):1006-1012.
16. Charra B. Control of blood pressure in long slow hemodialysis. Blood Purif. 1994; 12(4-5):252-258.
17. Tozawa M, Iseki K, Iseki C, Oshiro S, Yamazato M, Higashiuesato Y, Tomiyama N, Tana T, Ikemiya Y, Takishita S. Evidence for elevated pulse pressure in patients on chronic hemodialysis: A case-control study. Kidney Int. 2002; 62(6):2195-2201.
18. De Lima JJ, Vieira ML, Abensur H, Krieger EM. Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease. Nephrol Dial Transplant. 2001; 16(4):793-797.
19. Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl. 1996; 55:S173-S174.
20. Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE. Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int. 2002; 62(6):2281-2287.
21. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000; 58:2147-2154.
22. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14(12):3270-3277.
23. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99(18):2434-2439.
24. O'Rourke MF. Wave travel and reflection in the arterial system. J Hypertens. 1999; 17(Suppl 5):S45-S47.
25. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342(20): 1478-1483.
26. Salem MM. Hypertension in the haemodialysis population: Any relationship to 2-years survival? Nephrol Dial Transplant. 1999; 14(1):125-128.
27. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002; 287(12):1548-1555.
28. Benetos A. Pulse pressure and cardiovascular risk. J Hypertens. 1999; 17(Suppl 5):S21-S24.
29. Cruickshank JM. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 1988; 297(6658): 1227-1230.
30. Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Niemmen MS, Omvik P, Oparil S, Smapinn S, Wedel H; LIFE (Losaratan Intervention for Endpoint Reduction) Study Group. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA. 2002; 288(12):1491-1498.
31. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt DJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350(9080): 757-764.
32. Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002; 61(2):717-726.
33. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002; 62(5):1784-1790.
34. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies [published erratum appears in Lancet. 2003; 361(9362):1060]. Lancet. 2002; 360(9349):1903-13.
35. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis. 1997; 30(5): 659-664.
36. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001; 12(12):2759-2767.
37. Somes GW, Pahor M, Shorr RI et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999; 159(17):2004-2009.